The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey (Sprit)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Chinese Medical Doctor Association.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Lin Shen，MD & Ruihua Xu，MD、PhD, Chinese Medical Doctor Association
First received: March 6, 2012
Last updated: March 13, 2012
Last verified: March 2012
Collect the real clinical background of advanced colorectal cancer c of China.
Advanced Malignant Neoplasm
||Time Perspective: Cross-Sectional
||The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||December 2012 (Final data collection date for primary outcome measure)
The Primary Objectives of this study is collect the real clinical background of advanced colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment situation of colorectal cancer patients.
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Advanced Colorectal Cancer
- Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.
- Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01549067
|Peking University Cancer Hospital
|Beijing, Beijing, China |
|Contact: Lin Shen, MD 010-88140650 firstname.lastname@example.org |
|Principal Investigator: Lin Shen, MD |
|Sun Yat-sen University Cancer Center
|Zhongshan, Guangzhou, China |
|Contact: Rui-hua Xu, MD , PhD 020-87343468 email@example.com |
|Principal Investigator: Rui-hua Xu, MD , PhD |
Chinese Medical Doctor Association
||Lin Shen, MD
||Beijing Cancer Hospital
||Ruihua Xu, MD, PhD
||Sun Yat-sen University
No publications provided
||Lin Shen，MD & Ruihua Xu，MD、PhD, Principal Investigator, Chinese Medical Doctor Association
History of Changes
|Other Study ID Numbers:
|Study First Received:
||March 6, 2012
||March 13, 2012
||China: Ethics Committee
Keywords provided by Chinese Medical Doctor Association:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on August 27, 2015
Digestive System Diseases
Digestive System Neoplasms
Neoplasms by Site